Asterias Biotherapeutics, Inc. (AST) was a big mover last session, as the company saw its shares surge over 24% on the day. The upside came after the company announced that it has been added to the Russell 2000, Russell 3000, Russell Global, and Russell Microcap indexes. The news led to far more shares changing hands than in a normal session resulting in solid volume. This reverses the recent trend for the company as the stock is now down 60.5% in the past one-month time frame.
The company has seen one positive revision in the past one month, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for this stock. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Asterias Biotherapeutics currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.
A better-ranked stock in the same industry is Cambrex Corporation (CBM), sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment